HYPERURICEMIA
Clinical trials for HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERURICEMIA trials appear
Sign up with your email to follow new studies for HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gout pill shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new drug called LC350189 in 156 adults with gout and high uric acid. The goal was to see if it could safely lower uric acid levels over 12 weeks. Participants received one of three doses of the drug, a placebo, or an active comparator. The main measure was the…
Matched conditions: HYPERURICEMIA
Phase: PHASE2 • Sponsor: LG Chem • Aim: Disease control
Last updated May 17, 2026 06:20 UTC
-
New gout drug shows promise in major trial
Disease control CompletedThis study tested a new medicine called AR882 in 818 adults with gout. The goal was to see if it could lower uric acid levels below a target of 6 mg/dL over 6 to 12 months. Participants took either a low dose, a high dose, or a placebo pill. The results will show if AR882 is safe…
Matched conditions: HYPERURICEMIA
Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New gout drug shows promise in major trial
Disease control CompletedThis study tested a new medicine called tigulixostat in 354 adults with gout and high uric acid levels. The goal was to see if taking the drug for 6 months could safely lower uric acid below a target level. Participants received either one of three doses of tigulixostat or a plac…
Matched conditions: HYPERURICEMIA
Phase: PHASE3 • Sponsor: LG Chem • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Taiwan study tests smart devices for senior health
Knowledge-focused CompletedThis study looked at whether using smart devices and a cloud platform can help middle-aged and older adults in Taiwan better manage health issues like high blood pressure, diabetes, and weight. About 199 people from four communities used devices to track their health data, which …
Matched conditions: HYPERURICEMIA
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 06:22 UTC